International Journal of Molecular Sciences Review An Update on Pharmacological Potential of Boswellic Acids against Chronic Diseases Nand Kishor Roy 1, Dey Parama 1, Kishore Banik 1, Devivasha Bordoloi 1, Amrita Khwairakpam Devi 1, Krishan Kumar Thakur 1, Ganesan Padmavathi 1, Mehdi Shakibaei 2, Lu Fan 3, Gautam Sethi 3,* and Ajaikumar B. Kunnumakkara 1,* 1 Cancer Biology Laboratory and DBT-AIST International Centre for Translational and Environmental Research(DAICENTER), Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Assam 781039, India 2 Musculoskeletal Research Group and Tumour Biology, Chair of Vegetative Anatomy, Institute of Anatomy, Ludwig-Maximilian-University, 80336 Munich, Germany 3 Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore * Correspondence:
[email protected] (G.S.);
[email protected] or
[email protected](A.B.K.); Tel.: +65-65163267 (G.S.); +91-361-258-2231 or +91-789-600-5326 (A.B.K.); Fax: +65-68737690 (G.S.); +91-361-258-2249 (A.B.K.) Received: 24 July 2019; Accepted: 16 August 2019; Published: 22 August 2019 Abstract: Natural compounds, in recent years, have attracted significant attention for their use in the prevention and treatment of diverse chronic diseases as they are devoid of major toxicities. Boswellic acid (BA), a series of pentacyclic triterpene molecules, is isolated from the gum resin of Boswellia serrata and Boswellia carteri. It proved to be one such agent that has exhibited efficacy against various chronic diseases like arthritis, diabetes, asthma, cancer, inflammatory bowel disease, Parkinson’s disease, Alzheimer’s, etc. The molecular targets attributed to its wide range of biological activities include transcription factors, kinases, enzymes, receptors, growth factors, etc.